Extract from the Register of European Patents

EP Citations: EP2190881

Cited inInternational search
Type:Patent literature
Publication No.:EP1749537  [Y]
 (LAB FRANCAIS DU FRACTIONNEMENT [FR]) [Y] 1-23 * abstract *;
Type:Patent literature
Publication No.:EP1388544  [Y]
 (D COLLEN RES FOUNDATION VZW [BE]) [Y] 1-23 * abstract *;
Type:Patent literature
Publication No.:WO2005016455  [DY]
 (D COLLEN RES FOUNDATION VZW [BE], et al) [DY] 1-23 * example 12; sequences 29-32 *;
Type:Patent literature
Publication No.:WO2007096536  [E]
 (LAB FRANCAIS DU FRACTIONNEMENT [FR], et al) [E] 1-23 * the whole document *;
Type:Patent literature
Publication No.:FR2897868  [E]
 (LAB FRANCAIS DU FRACTIONNEMENT [FR]) [E] 1-23 * Identique à la présente demande.;; claims 1-29 *
Type:Non-patent literature
Publication information:[Y]  - GILLES JEAN GUY G ET AL, "A limited number of anti-idiotypic antibodies is required to maintain FVIII function in presence of polyclonal anti-FVIII antibodies of haemophilia a patients with inhibitors.", BLOOD, & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006, (200611), vol. 108, no. 11, Part 1, ISSN 0006-4971, page 299A, XP009099673 [Y] 1-23 * the whole document *
Type:Non-patent literature
Publication information:[Y]  - GILLES JEAN GUY G ET AL, "In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody", BLOOD, (20040401), vol. 103, no. 7, ISSN 0006-4971, pages 2617 - 2623, XP002479159 [Y] 1-23 * abstract *
DOI: http://dx.doi.org/10.1182/blood-2003-07-2207
Type:Non-patent literature
Publication information:[A]  - PIPE S W ET AL, "New high-technology products for the treatment of haemophilia", HAEMOPHILIA, BLACKWELL SCIENCE, OXFORD, GB, (20041001), vol. 10, no. SUPPL 4, ISSN 1351-8216, pages 55 - 63, XP002404355 [A] * page 58, column R, paragraph 2 - page 59, column L, paragraph 1 *